Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
XLO	XILIO THERAPEUTICS INC	$0.77	1.32%	-3.53%	5.80%	10.22%	-44.09%	-26.35%	-78.11%	N/A	N/A	$1.70	$0.62	54.94%	23.55%	0.90	178,132	42.78%
ZLAB	ZAI LAB LTD	$31.69	-0.47%	-5.74%	-12.31%	13.83%	2.76%	100.57%	-19.87%	-49.47%	N/A	$39.77	$15.80	20.32%	100.54%	1.20	634,760	-43.28%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$6.00	0.17%	2.04%	-55.09%	N/A	N/A	N/A	N/A	N/A	N/A	$25.00	$5.21	76.00%	15.16%	-1.96	37,640	4.85%
ITOS	ITEOS THERAPEUTICS INC	$7.25	5.84%	1.40%	21.44%	-5.60%	-15.60%	-32.50%	-74.11%	N/A	N/A	$18.75	$4.80	61.33%	51.04%	1.05	816,575	91.60%
VALN	VALNEVA SE	$6.35	-1.63%	-9.15%	-5.44%	20.86%	8.46%	-14.83%	-75.93%	N/A	N/A	$9.50	$3.62	33.21%	75.28%	1.03	14,897	-33.45%
MDCX	MEDICUS PHARMA LTD	$4.20	4.84%	7.24%	13.01%	54.56%	N/A	N/A	N/A	N/A	N/A	$4.99	$1.80	15.75%	133.56%	0.56	10,481	-74.80%
AXSM	AXSOME THERAPEUTICS INC	$112.29	2.16%	7.73%	-3.72%	3.16%	25.52%	52.24%	229.88%	18.16%	N/A	$139.13	$64.11	19.29%	75.15%	0.94	640,710	2.18%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$2.39	-2.45%	-2.45%	-20.33%	-55.74%	-76.45%	N/A	N/A	N/A	N/A	$17.31	$1.78	86.19%	34.27%	1.14	107,773	-30.22%
PVLA	PALVELLA THERAPEUTICS INC	$24.28	3.58%	-8.58%	-13.25%	79.85%	43.92%	107.34%	-88.63%	-88.55%	-89.88%	$29.27	$6.20	17.05%	291.61%	0.86	148,443	-29.72%
XCUR	EXICURE INC	$10.45	-4.30%	-7.19%	-21.66%	-3.33%	298.85%	305.04%	-45.57%	-96.70%	N/A	$36.00	$1.44	70.97%	625.69%	0.91	11,176	34.00%
MDWD	MEDIWOUND LTD	$17.71	-2.51%	-1.47%	14.08%	-10.94%	-2.29%	-4.86%	42.90%	26.46%	-57.13%	$24.00	$12.78	26.23%	38.54%	0.74	34,052	59.16%
TCRX	TSCAN THERAPEUTICS INC	$1.61	0.94%	-1.53%	16.30%	-37.79%	-66.07%	-79.21%	-24.29%	N/A	N/A	$9.69	$1.02	83.44%	57.35%	0.67	288,677	-5.60%
SEER	SEER INC	$1.99	3.11%	-2.45%	17.75%	-15.68%	0.51%	-4.33%	-76.48%	N/A	N/A	$2.63	$1.56	24.19%	27.56%	1.84	243,020	64.97%
ATYR	ATYR PHARMA INC	$3.47	2.66%	-1.42%	14.90%	-7.22%	10.86%	121.02%	-17.18%	-3.34%	N/A	$4.66	$1.42	25.54%	144.37%	0.85	744,473	-28.30%
ALEC	ALECTOR INC	$1.20	6.19%	3.45%	-2.44%	-30.23%	-76.47%	-76.38%	-88.10%	-95.15%	N/A	$6.78	$0.87	82.30%	37.93%	1.47	1,538,269	312.40%
LENZ	LENZ THERAPEUTICS INC	$28.52	7.08%	5.81%	10.91%	11.91%	3.17%	79.68%	1.59%	N/A	N/A	$38.93	$14.42	26.75%	97.75%	1.30	286,596	66.47%
MREO	MEREO BIOPHARMA GROUP PLC	$2.59	2.78%	1.17%	15.11%	-11.60%	-39.06%	-15.08%	309.16%	89.05%	N/A	$5.02	$1.58	48.41%	64.44%	1.00	782,247	108.56%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$4.83	6.15%	1.68%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$5.81	$3.51	16.87%	37.61%	-1.37	33,064	-93.34%
XNCR	XENCOR INC	$11.02	4.16%	1.38%	3.57%	-40.43%	-47.57%	-47.37%	-57.63%	-62.30%	-22.50%	$27.24	$7.16	59.54%	53.91%	1.07	803,379	48.53%
ZBIO	ZENAS BIOPHARMA INC	$11.58	3.39%	16.85%	46.58%	51.97%	-44.86%	N/A	N/A	N/A	N/A	$26.25	$5.83	55.89%	98.63%	1.23	148,790	-11.26%
ORMP	ORAMED PHARMACEUTICALS INC	$2.32	-0.43%	0.43%	8.41%	5.45%	-3.73%	0.00%	-58.79%	-24.92%	-67.80%	$3.09	$1.82	24.92%	27.47%	1.07	79,301	104.95%
REGN	REGENERON PHARMACEUTICALS INC	$598.76	5.25%	1.86%	-5.59%	-12.34%	-35.11%	-32.77%	-8.17%	13.86%	30.89%	$1.21k	$525.99	50.56%	13.83%	0.59	1,616,921	-39.22%
TRAW	TRAWS PHARMA INC	$1.45	1.40%	0.00%	-36.96%	-80.11%	-70.82%	-91.21%	-95.80%	-98.77%	-100.00%	$19.44	$1.36	92.54%	6.62%	0.73	31,544	-16.29%
ABVC	ABVC BIOPHARMA INC	$1.06	2.91%	21.00%	0.00%	103.85%	47.22%	-15.20%	-95.57%	N/A	N/A	$1.40	$0.40	24.29%	165.00%	0.46	189,034	39.40%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$1.70	6.25%	7.59%	9.68%	-32.54%	-40.77%	-69.48%	-27.97%	-95.41%	N/A	$7.66	$1.20	77.81%	42.26%	1.42	733,876	97.25%
TRDA	ENTRADA THERAPEUTICS INC	$9.13	2.13%	4.82%	1.00%	-31.71%	-47.01%	-22.95%	41.33%	N/A	N/A	$21.79	$7.10	58.10%	28.59%	1.04	126,235	17.24%
ZYME	ZYMEWORKS INC	$13.01	2.52%	4.50%	9.24%	-11.74%	-6.20%	51.63%	89.37%	-64.39%	N/A	$17.70	$8.21	26.50%	58.47%	0.93	555,071	62.33%
RYTM	RHYTHM PHARMACEUTICALS INC	$65.19	-0.05%	8.94%	23.07%	10.08%	31.59%	63.96%	934.76%	246.02%	N/A	$68.58	$35.17	4.94%	85.36%	1.22	402,296	10.48%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$38.98	2.39%	4.48%	7.65%	-10.18%	-24.81%	-8.37%	-46.08%	-35.50%	-30.92%	$60.37	$29.59	35.43%	31.73%	1.09	747,412	-4.42%
PRME	PRIME MEDICINE INC	$1.73	8.13%	-2.81%	-13.07%	-38.87%	-57.49%	-64.84%	N/A	N/A	N/A	$8.27	$1.12	79.08%	55.16%	1.90	1,188,017	31.71%
FTRE	FORTREA HOLDINGS INC	$6.23	-1.58%	17.11%	-17.48%	-62.81%	-63.67%	-82.97%	N/A	N/A	N/A	$37.67	$4.77	83.46%	30.61%	1.55	1,687,684	3.53%
RLAY	RELAY THERAPEUTICS INC	$3.33	7.42%	7.07%	27.10%	-26.65%	-41.68%	-48.93%	-86.54%	N/A	N/A	$10.72	$1.78	68.94%	87.61%	1.70	4,072,564	164.26%
VTVT	VTV THERAPEUTICS INC	$19.95	-3.99%	-2.92%	15.18%	36.11%	39.61%	-28.49%	-21.46%	-76.25%	N/A	$29.09	$12.12	31.42%	64.60%	0.82	5,089	-90.49%
PHIO	PHIO PHARMACEUTICALS CORP	$1.92	-3.03%	-5.88%	47.69%	-13.51%	-39.05%	-69.30%	-97.88%	-99.07%	-100.00%	$9.79	$0.97	80.39%	98.76%	1.05	176,371	-26.86%
NNNN	ANBIO BIOTECHNOLOGY	$6.10	-5.13%	-10.95%	-18.23%	N/A	N/A	N/A	N/A	N/A	N/A	$7.82	$5.18	21.99%	17.76%	-0.05	15,842	-22.17%
SION	SIONNA THERAPEUTICS INC	$12.03	-0.08%	-8.10%	15.01%	N/A	N/A	N/A	N/A	N/A	N/A	$25.19	$7.26	52.24%	65.82%	0.69	84,999	-41.58%
AARD	AARDVARK THERAPEUTICS INC	$11.11	-2.80%	30.40%	47.94%	N/A	N/A	N/A	N/A	N/A	N/A	$19.58	$4.88	43.26%	127.66%	1.21	68,558	-12.41%
NEUP	NEUPHORIA THERAPEUTICS INC	$5.07	-2.03%	-0.78%	-11.98%	-6.28%	114.01%	-55.53%	-94.29%	N/A	N/A	$15.24	$2.12	66.73%	138.70%	0.75	6,816	10.76%
SMMT	SUMMIT THERAPEUTICS INC	$24.12	2.12%	-27.41%	25.04%	7.87%	29.33%	513.74%	1,575.00%	543.20%	131.03%	$36.91	$2.10	34.65%	1,048.57%	0.58	4,371,527	3.35%
OABI	OMNIAB INC	$1.70	-8.11%	-8.11%	-29.17%	-47.04%	-57.39%	-61.71%	-83.15%	-83.59%	N/A	$4.96	$1.66	65.73%	2.41%	0.51	6,232,184	688.90%
GNLX	GENELUX CORP	$2.69	-9.43%	-7.24%	-0.37%	-31.55%	-19.22%	-13.50%	N/A	N/A	N/A	$5.89	$1.60	54.29%	68.13%	1.28	154,622	157.09%
ASMB	ASSEMBLY BIOSCIENCES INC	$11.39	-1.04%	9.41%	19.14%	-21.07%	-33.08%	-8.66%	-46.97%	-94.58%	-92.87%	$19.93	$7.75	42.85%	46.97%	0.91	17,083	-14.07%
RADX	RADIOPHARM THERANOSTICS LTD	$3.91	-2.25%	-3.46%	-18.71%	-17.68%	N/A	N/A	N/A	N/A	N/A	$50.82	$3.50	92.31%	11.84%	0.45	18,339	163.42%
RAPP	RAPPORT THERAPEUTICS INC	$11.45	3.57%	0.62%	14.16%	-31.23%	-57.34%	N/A	N/A	N/A	N/A	$29.74	$6.43	61.50%	78.07%	1.28	98,157	22.05%
BPMC	BLUEPRINT MEDICINES CORP	$89.50	1.15%	4.30%	1.12%	-21.53%	0.29%	-2.01%	49.87%	52.13%	374.30%	$121.90	$73.04	26.58%	22.54%	1.15	1,106,569	92.94%
MGNX	MACROGENICS INC	$1.74	8.44%	1.46%	36.61%	-42.36%	-48.97%	-88.26%	-77.14%	-75.90%	-93.94%	$16.44	$0.99	89.45%	75.25%	1.17	873,957	137.27%
IPSC	CENTURY THERAPEUTICS INC	$0.54	7.54%	0.37%	13.87%	-36.24%	-57.66%	-81.37%	-95.60%	N/A	N/A	$3.70	$0.34	85.35%	58.48%	1.25	456,531	-48.51%
NRSN	NEUROSENSE THERAPEUTICS LTD	$0.98	1.03%	-0.71%	5.38%	-7.55%	-24.62%	-27.41%	-37.97%	N/A	N/A	$1.50	$0.51	34.67%	91.41%	0.51	53,685	-4.47%
CYTK	CYTOKINETICS INC	$42.84	3.75%	12.74%	6.59%	-14.27%	-16.51%	-30.14%	7.29%	183.52%	581.08%	$68.44	$32.74	37.41%	30.85%	1.00	1,723,015	60.29%
EVAX	EVAXION BIOTECH A	$1.53	2.00%	2.68%	-17.30%	-38.06%	-88.91%	-92.66%	-98.94%	N/A	N/A	$20.81	$1.20	92.65%	27.50%	0.52	40,059	-39.31%
PGEN	PRECIGEN INC	$1.56	1.30%	-3.70%	4.70%	14.71%	89.32%	18.18%	11.43%	-56.67%	-95.98%	$2.17	$0.65	28.11%	139.63%	1.73	743,537	-44.14%
IMTX	IMMATICS NV	$5.00	2.67%	10.86%	10.86%	-7.41%	-45.83%	-49.65%	-36.47%	-53.14%	N/A	$13.77	$3.30	63.69%	51.52%	0.88	349,294	11.20%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$3.59	0.84%	12.54%	7.81%	-42.19%	-67.48%	-69.52%	-78.10%	-88.83%	-69.91%	$14.23	$2.70	74.77%	32.96%	1.43	7,064,620	12.70%
TSHA	TAYSHA GENE THERAPIES INC	$1.94	6.59%	6.59%	39.57%	31.08%	3.74%	-20.16%	-50.76%	N/A	N/A	$4.32	$1.05	55.09%	84.76%	1.80	1,027,268	-18.78%
YMAB	Y-MABS THERAPEUTICS INC	$4.25	1.19%	3.16%	-4.06%	-31.34%	-71.38%	-72.06%	-52.83%	-87.34%	N/A	$17.78	$3.84	76.09%	10.68%	1.49	169,597	11.28%
ERAS	ERASCA INC	$1.46	2.10%	2.82%	6.57%	-22.34%	-45.93%	-27.36%	-81.54%	N/A	N/A	$3.45	$1.01	57.68%	44.55%	1.44	739,520	-76.60%
RNAC	CARTESIAN THERAPEUTICS INC	$12.00	0.84%	3.18%	-8.95%	-38.08%	-43.24%	-45.63%	-50.00%	-85.19%	N/A	$41.87	$8.85	71.34%	35.59%	1.31	43,656	-9.80%
ITRM	ITERUM THERAPEUTICS PLC	$1.12	5.66%	-19.42%	-8.94%	-28.66%	-7.44%	-26.80%	-71.50%	-97.87%	N/A	$3.02	$0.81	62.91%	38.61%	1.08	669,218	-42.39%
IMCR	IMMUNOCORE HOLDINGS PLC	$30.10	-1.21%	1.01%	1.45%	-7.70%	-5.67%	-49.05%	-12.50%	N/A	N/A	$62.74	$23.15	52.02%	30.02%	0.74	127,183	51.89%
CGEN	COMPUGEN LTD	$1.60	14.29%	11.11%	9.59%	-31.91%	-2.44%	-17.10%	-31.33%	-88.96%	-75.04%	$2.66	$1.13	39.85%	41.59%	1.70	336,464	106.99%
VRDN	VIRIDIAN THERAPEUTICS INC	$13.55	2.81%	0.30%	0.52%	-32.52%	-38.88%	2.19%	4.88%	45.32%	-96.81%	$27.20	$9.90	50.18%	36.87%	0.60	580,830	25.40%
AVXL	ANAVEX LIFE SCIENCES CORP	$9.50	-1.35%	2.04%	10.72%	-0.73%	66.37%	160.27%	4.97%	174.57%	718.97%	$14.44	$3.51	34.22%	170.66%	1.67	634,838	44.03%
PRLD	PRELUDE THERAPEUTICS INC	$0.96	6.55%	8.72%	25.00%	-19.33%	-27.27%	-74.54%	-80.25%	N/A	N/A	$6.80	$0.61	85.88%	57.38%	1.42	140,875	167.04%
NRXP	NRX PHARMACEUTICALS INC	$2.12	3.16%	7.07%	3.41%	-29.10%	48.25%	-17.83%	-86.32%	-98.21%	N/A	$6.01	$1.10	64.73%	92.73%	0.87	241,624	152.67%
FATE	FATE THERAPEUTICS INC	$1.28	9.40%	-3.76%	62.03%	-6.57%	-48.59%	-67.59%	-95.70%	-95.33%	-73.77%	$5.92	$0.66	78.38%	93.65%	1.65	2,086,163	51.94%
BDRX	BIODEXA PHARMACEUTICALS PLC	$1.46	-2.01%	2.82%	10.61%	-65.57%	-76.45%	-96.13%	-99.99%	-100.00%	N/A	$74.00	$1.14	98.03%	28.07%	0.89	15,701	-69.74%
MAIA	MAIA BIOTECHNOLOGY INC	$2.34	1.74%	14.15%	52.94%	25.81%	-16.43%	-20.14%	N/A	N/A	N/A	$5.99	$1.40	60.93%	67.14%	0.49	369,459	28.34%
TARA	PROTARA THERAPEUTICS INC	$3.50	2.94%	-16.67%	-17.84%	-22.22%	49.57%	17.45%	-2.78%	-85.71%	-99.27%	$10.48	$1.60	66.60%	119.44%	1.04	556,437	-16.53%
DNLI	DENALI THERAPEUTICS INC	$16.65	0.91%	11.97%	22.47%	-29.39%	-37.99%	7.84%	-33.80%	-23.83%	N/A	$33.33	$10.57	50.05%	57.52%	1.52	1,911,968	25.68%
BLTE	BELITE BIO INC	$61.48	-1.32%	4.56%	-7.16%	3.15%	1.54%	51.43%	593.12%	N/A	N/A	$86.53	$39.19	28.95%	56.88%	0.16	10,711	-73.88%
SLS	SELLAS LIFE SCIENCES GROUP INC	$1.55	8.39%	18.32%	43.52%	16.54%	30.25%	25.00%	-45.61%	-38.74%	-100.00%	$1.84	$0.77	15.76%	100.78%	1.05	1,699,547	-50.37%
VIVS	VIVOSIM LABS INC	$1.95	14.04%	-4.41%	-12.95%	-53.43%	-64.08%	-84.81%	-94.25%	-98.08%	-99.82%	$21.96	$1.56	91.12%	25.00%	0.74	242,505	95.37%
ADCT	ADC THERAPEUTICS SA	$1.43	0.70%	10.85%	1.42%	-16.86%	-51.53%	-67.57%	-88.00%	N/A	N/A	$5.17	$1.05	72.34%	36.19%	1.18	204,979	8.40%
COYA	COYA THERAPEUTICS INC	$6.59	8.03%	0.46%	1.85%	12.46%	-0.98%	-27.18%	N/A	N/A	N/A	$10.24	$4.65	35.64%	41.72%	0.94	48,993	61.30%
ACTU	ACTUATE THERAPEUTICS INC	$9.20	0.44%	2.22%	35.89%	4.19%	7.48%	N/A	N/A	N/A	N/A	$11.73	$5.51	21.57%	66.97%	0.64	25,292	-24.87%
RZLT	REZOLUTE INC	$3.76	-2.59%	-5.29%	29.66%	-27.83%	-30.88%	40.30%	-2.34%	N/A	N/A	$6.19	$2.22	39.22%	69.75%	0.69	457,834	-43.38%
INSM	INSMED INC	$72.00	0.84%	1.69%	-5.62%	-5.62%	2.43%	191.26%	220.71%	213.04%	259.28%	$84.91	$21.92	15.20%	228.47%	1.05	1,493,000	-19.15%
JAGX	JAGUAR HEALTH INC	$12.24	2.09%	83.51%	157.14%	-45.60%	-53.81%	-96.20%	-99.98%	-99.99%	N/A	$540.00	$4.02	97.73%	204.48%	1.24	217,472	-37.44%
ALXO	ALX ONCOLOGY HOLDINGS INC	$0.54	5.88%	-6.90%	-13.32%	-58.62%	-60.87%	-96.83%	-95.85%	N/A	N/A	$17.83	$0.46	96.97%	17.39%	1.25	390,131	-36.74%
SGMO	SANGAMO THERAPEUTICS INC	$0.77	7.07%	2.39%	17.68%	-37.24%	-61.21%	49.90%	-82.61%	-90.53%	-93.76%	$3.18	$0.30	75.72%	153.95%	1.45	2,858,483	6.74%
PSTV	PLUS THERAPEUTICS INC	$0.72	-6.50%	-26.93%	-24.32%	-40.08%	-45.53%	-58.68%	-92.74%	-97.02%	-100.00%	$2.67	$0.24	73.07%	199.58%	0.66	1,012,939	-12.80%
NAMS	NEWAMSTERDAM PHARMA CO NV	$19.13	3.13%	10.77%	-6.55%	-12.13%	6.28%	-12.29%	94.02%	N/A	N/A	$27.29	$14.06	29.90%	36.06%	0.38	806,236	90.13%
ACIU	AC IMMUNE SA	$1.73	1.76%	9.49%	-7.49%	-35.93%	-41.75%	-30.24%	-49.71%	-75.67%	N/A	$4.98	$1.43	65.25%	20.98%	1.04	210,962	101.20%
TECX	TECTONIC THERAPEUTIC INC	$20.86	3.14%	6.76%	17.79%	-61.96%	-49.20%	46.08%	87.14%	-86.49%	N/A	$61.07	$13.70	65.84%	52.26%	1.19	109,687	4.74%
QTTB	Q32 BIO INC	$1.60	2.89%	-15.79%	-3.03%	-50.92%	-96.55%	-94.16%	-94.77%	-99.26%	N/A	$53.79	$1.38	97.03%	15.94%	1.10	1,102,123	254.67%
BCAX	BICARA THERAPEUTICS INC	$14.37	-3.43%	-7.35%	10.28%	11.31%	-39.37%	N/A	N/A	N/A	N/A	$28.09	$8.91	48.84%	61.28%	1.36	584,055	25.51%
TIL	INSTIL BIO INC	$12.85	9.64%	-37.38%	-25.98%	-46.48%	-62.51%	18.76%	-91.43%	N/A	N/A	$92.00	$9.62	86.03%	33.58%	1.69	298,631	80.09%
FBIO	FORTRESS BIOTECH INC	$1.77	1.14%	12.03%	13.46%	-0.56%	-8.76%	5.99%	-88.43%	-94.41%	-96.19%	$2.89	$1.33	38.75%	33.58%	1.20	180,507	33.58%
MCRB	SERES THERAPEUTICS INC	$9.70	3.19%	-0.31%	-30.72%	-43.37%	-38.04%	-51.04%	-90.24%	-86.82%	N/A	$30.60	$7.18	68.30%	35.12%	1.33	130,941	132.79%
IMMP	IMMUTEP LTD	$1.71	-1.16%	5.56%	-2.84%	-17.39%	-12.31%	-36.43%	-29.05%	69.31%	-8.41%	$3.34	$1.32	48.73%	29.55%	0.96	32,153	-33.06%
UNCY	UNICYCIVE THERAPEUTICS INC	$0.65	1.24%	2.84%	13.39%	12.41%	27.84%	-41.79%	-25.91%	N/A	N/A	$1.21	$0.20	46.12%	222.77%	0.69	878,267	417.52%
SAVA	CASSAVA SCIENCES INC	$1.56	0.00%	-6.02%	4.00%	-34.45%	-94.00%	-92.96%	-92.50%	-79.57%	-89.08%	$42.20	$1.15	96.30%	35.65%	1.36	630,450	33.92%
ACOG	ALPHA COGNITION INC	$5.52	4.74%	12.20%	9.09%	-8.00%	N/A	N/A	N/A	N/A	N/A	$7.00	$3.75	21.14%	47.20%	0.87	101,884	106.70%
OCUL	OCULAR THERAPEUTIX INC	$8.30	1.10%	5.73%	13.23%	6.68%	-25.09%	75.11%	108.54%	44.10%	-62.19%	$11.78	$4.79	29.51%	73.28%	1.48	1,002,571	12.45%
THRD	THIRD HARMONIC BIO INC	$5.17	0.39%	0.39%	48.99%	-3.36%	-63.57%	-53.59%	N/A	N/A	N/A	$16.94	$3.18	69.48%	62.58%	0.78	304,099	35.73%
NRIX	NURIX THERAPEUTICS INC	$11.53	0.79%	-0.69%	-2.95%	-42.39%	-52.10%	-4.08%	-3.60%	N/A	N/A	$29.56	$8.18	60.99%	40.95%	1.51	747,531	36.25%
ARVN	ARVINAS INC	$9.62	2.67%	6.06%	37.04%	-46.23%	-65.22%	-69.72%	-82.84%	-81.68%	N/A	$37.38	$5.94	74.26%	62.09%	1.33	1,524,077	-10.39%
AVBP	ARRIVENT BIOPHARMA INC	$21.26	1.72%	0.85%	14.98%	-26.92%	-32.44%	28.69%	N/A	N/A	N/A	$36.37	$15.47	41.55%	37.43%	0.83	183,727	88.78%
PRTA	PROTHENA CORP PUBLIC LTD CO	$9.20	-5.06%	-4.07%	-25.66%	-37.41%	-49.12%	-54.77%	-69.96%	-18.00%	-71.61%	$25.42	$9.00	63.81%	2.22%	1.41	988,865	121.74%
GERN	GERON CORP	$1.41	2.17%	1.44%	-11.32%	-51.04%	-66.02%	-64.12%	-5.37%	18.49%	-61.05%	$5.34	$1.17	73.60%	20.51%	1.14	8,673,695	19.14%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: A.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 169.3% over the past year, overperforming other biotech stocks by 246 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 388.6% from Protalix Biotherapeutics's current stock price of $3.07.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.89% over the past year, overperforming other biotech stocks by 139 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 61.4% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.68% from Catalyst Pharmaceuticals's current stock price of $24.29.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.97%, which is 5 percentage points higher than the biotech industry average of 1.92%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.43%, which is 1 percentage points higher than the biotech industry average of 1.92%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.31%, which is -1 percentage points lower than the biotech industry average of 1.92%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.74% in the last day, and up 4.52% over the last week. Regulus Therapeutics was the among the top gainers in the biotechnology industry, gaining 136.8% yesterday.

Regulus Therapeutics shares are trading higher after the company announced it entered into an agreement to be acquired by Novartis AG for $7 in cash per share.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -4.66% in the past year. It has overperformed other stocks in the biotech industry by 72 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.28% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 5.61% in the past year. It has overperformed other stocks in the biotech industry by 82 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.94% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.14% of biotech stocks are rated B (Buy), 42.05% are rated C (Hold), 36.38% are rated D (Sell), and 15.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -162.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.